Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria

NCT00371735 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria, Falciparum

Interventions

DRUG: chlorproguanil-dapsone-artesunate
DRUG: chlorproguanil-dapsone

Sponsor

GlaxoSmithKline